EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD

Amod Sharma iD, Reza Hakkak iD, Shannon Rose iD, Neriman Gokden, Nirmala Parajuli iD

Nutrients · 24.06.2026 · 18 (13) · 2061

DOI: 10.3390/nu18132061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nutrients, online erschienen am 24.06.2026. Verfasst von Amod Sharma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA. Hauptthemen laut MEDLINE: Energy Metabolism, Obesity, Mitochondria, Kidney. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, Arkansas Biosciences Institute, NIH NIDDK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Obesity-associated non-alcoholic fatty liver disease (NAFLD) drives systemic metabolic stress and accelerates chronic kidney disease, yet the mechanistic links remain unclear. Mitochondrial dysfunction has emerged as a central mediator of obesity-induced organ injury. Here, we investigated renal mitochondrial remodeling in a rat model of obesity-associated NAFLD (Ob-NAFLD) and examined the effects of metformin.

Methods

Female Zucker rats (obese fa/fa and lean Fa/Fa) were fed an AIN-93G diet for eight weeks, followed by 10 weeks of metformin treatment in designated groups. Kidney tissues were analyzed using biochemical assays, immunoblotting, blue native PAGE, in-gel activity assays, and histological evaluation.

Results

In Ob-NAFLD rats, renal ATP levels were elevated despite reduced electron transport chain (ETC) Complex III and increased Complex V expression, reflecting compensatory ATP synthase hyperactivity uncoupled from efficient oxidative phosphorylation. Mitochondrial dynamics were disrupted such that inhibitory phosphorylation of DRP1 was reduced, promoting fission, and total OPA1 expression was decreased with a shift in short-to-long isoform balance, indicating impaired fusion and cristae remodeling. Notably, ATPase inhibitory factor 1 (IF1), a checkpoint that limits ATP synthase overdrive, remained stably expressed, suggesting an adaptive ceiling or failed protective control under chronic metabolic stress. Metformin partially alleviated bioenergetic stress by lowering ATP and modestly restoring Complex III, yet ETC imbalance and structural remodeling persisted, revealing the limitations of metabolic modulation alone.

Conclusions

These findings position entrenched mitochondrial dysregulation as a mechanistic bridge linking obesity-driven liver disease to kidney injury. Therapeutic strategies combining metabolic interventions with targeted restoration of ETC coordination, mitochondrial dynamics, and regulatory checkpoints such as IF1 may be required to fully restore renal mitochondrial health and prevent the progression of metabolic kidney disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Energy MetabolismObesityMitochondriaKidneyNon-alcoholic Fatty Liver DiseaseAnimalsFemaleRats, ZuckerMetforminRatsMitochondrial DynamicsAdenosine TriphosphateDisease Models, AnimalDynaminsGTP Phosphohydrolases

Stichwörter der Autor:innen

ATPkidney injurymetforminmitochondrial dynamicsobesity–NAFLD

Substanzen

MetforminAdenosine TriphosphateDynaminsOpa1 protein, ratDnm1l protein, ratGTP Phosphohydrolases

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Department of Dietetics and Nutrition, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
  • Arkansas Children's Research Institute, Little Rock, AR 72202, USA.
  • Department of Health Promotion and Disease Prevention, College of Nursing, The University of Tennessee Health Science Center, Memphis, TN 38103, USA.
  • Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.

ORCID-Profile: Amod Sharma, Reza Hakkak, Shannon Rose, Nirmala Parajuli

Förderung

  • NIDDK NIH HHS
  • Arkansas Biosciences Institute
  • NIH NIDDK
  • Arkansas Bioscience Institute

Zitieren

APA

Sharma, A., Hakkak, R., Rose, S., Gokden, N., & Parajuli, N. (2026). Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD. Nutrients, 18(13), 2061. https://doi.org/10.3390/nu18132061

Vancouver

Sharma A, Hakkak R, Rose S, Gokden N, Parajuli N. Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD. Nutrients. 2026;18(13):2061. doi:10.3390/nu18132061

BibTeX
@article{Sharma2026,
  author = {Sharma, Amod and Hakkak, Reza and Rose, Shannon and Gokden, Neriman and Parajuli, Nirmala},
  title = {Impaired Renal Mitochondria and Bioenergetics During Obesity-Associated NAFLD},
  journal = {Nutrients},
  year = {2026},
  volume = {18},
  number = {13},
  pages = {2061},
  doi = {10.3390/nu18132061}
}
Kostenlos starten →